Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis
Authors
Keywords
-
Journal
NEUROGASTROENTEROLOGY AND MOTILITY
Volume 29, Issue 2, Pages e12926
Publisher
Wiley
Online
2016-08-31
DOI
10.1111/nmo.12926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
- (2015) S. E. Attwood et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton pump inhibitors and vascular function: A prospective cross-over pilot study
- (2015) Yohannes T Ghebremariam et al. VASCULAR MEDICINE
- Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
- (2015) Nigam H. Shah et al. PLoS One
- Proton pump inhibitor use represents an independent risk factor for myocardial infarction
- (2014) Chia-Jen Shih et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease
- (2013) D. A. Peura et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
- (2013) Philip O Katz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use
- (2013) Mette Charlot ANNALS OF INTERNAL MEDICINE
- Unexpected Effect of Proton Pump Inhibitors
- (2013) Yohannes T. Ghebremariam et al. CIRCULATION
- Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
- (2013) David N. Juurlink et al. PLoS One
- Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Nigel W Flook et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor
- (2012) Shaun G. Goodman et al. CIRCULATION
- Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography
- (2011) Tse-Min Lu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effect of Esomeprazole 40 mg Once or Twice Daily on Asthma
- (2010) Toni O. Kiljander et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Failing the Acid Test
- (2010) Mitchell H. Katz ARCHIVES OF INTERNAL MEDICINE
- A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine
- (2010) Hasan Ari et al. HEART AND VESSELS
- The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease
- (2010) Elizabeth A. Friedlander et al. Journal of the American Academy of Nurse Practitioners
- Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
- (2010) Andrew M Wilson et al. VASCULAR MEDICINE
- Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
- (2009) C. W. HOWDEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
- (2009) Loren Laine et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
- (2009) Jeremy A. Rassen et al. CIRCULATION
- Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
- (2009) Rainer H. Böger et al. CIRCULATION
- Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis
- (2009) Lars Lundell et al. Clinical Gastroenterology and Hepatology
- Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole
- (2009) Thomas O. Kovacs et al. DIGESTIVE DISEASES AND SCIENCES
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of combining PPIs with thienopyridines: fact or fiction?
- (2009) Dirk Sibbing et al. LANCET
- Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial
- (2008) L Lundell et al. GUT
- Gastroesophageal Reflux Disease
- (2008) Peter J. Kahrilas NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now